Yancoal's Q3 2025 report shows steady output and stable costs. Near-term upside from the Glencore-Taipower dispute is ...

Dycom (DY) is a strong buy, backed by robust growth, new data center markets, and solid valuation. Read here for an analysis ...

Global Ship Lease (GSL) offers upside potential, a 7.1% yield, and strong dividend safety. See here to know why analysts rate ...

Ibotta stock faces stalled growth, margin pressure, and profitability concerns despite buybacks. Read here for more analysis ...

Vanda advances with strong Fanapt growth, late-stage catalysts, GLP-1 potential, higher investment and solid balance sheet ...

AI adoption continues to gain momentum across organization sizes, with 53% of small and medium-sized enterprises and 61% of ...

Semtech faces Q3 with strong AI and data center drivers, aligned estimates, 800G growth and steady IoT but exposure risks.

Clinical-stage pharmaceutical company Inhibikase Therapeutics (IKT) announced the pricing of its underwritten public offering, anticipating gross proceeds of approximately $100.0 million. The company ...

GDV preferreds offer Aa3 ratings, near 6% stable yields, low credit risk, below-par shares and cumulative distributions. See ...

Unpack the Wasatch Frontier Emerging Small Countries Fund's Q3 2025 results, market insights, and top holdings. Read more to ...

Macy's shows soft sales, resilient broad operations, strong fundamentals, solid capital, low valuation, and bullish ...

Expectations are high that the U.S. Supreme Court will rule against the Trump administration’s use of the International ...